The anti-snoring devices market has seen considerable growth due to a variety of factors.
•The market size of anti-snoring devices has seen a significant surge in growth in the past few years. The market, which was worth $1.78 billion in 2024, is projected to reach $1.92 billion in 2025, expanding at a compound annual growth rate (CAGR) of 8.0%.
Factors catalysing this growth include heightened awareness about sleep disorders, understanding the health hazards related to snoring, the rise in the aged population and the prevalence of snoring, its effect on sleep quality, as well as easily accessible non-invasive treatments and over-the-counter solutions.
The anti-snoring devices market is expected to maintain its strong growth trajectory in upcoming years.
• In the upcoming years, the anti-snoring devices market is projected to experience a rapid expansion, reaching $2.89 billion in market value by 2029, a growth facilitated by a compound annual growth rate (CAGR) of 10.8%.
Factors contributing to this market growth during the forecast period include an increased emphasis on sleep health, the rise of lifestyle-related factors, improvements in design and comfort, the growth of online retail and e-commerce, and the availability of customized and personalized solutions. Notable market trends to be seen in the forecast period include neuromodulation technologies, incorporation of biofeedback mechanisms, emphasis on comfort and user experience, collaborations with sleep clinics and professionals, expansion in retail channels, and continued growth in e-commerce.
The surge in obesity rates is predicted to fuel the expansion of the anti-snoring devices market in the future. Obesity is typically defined as abnormal or excessive weight gain that poses a health risk. Anti-snoring devices such as mouthpieces help those struggling with obesity to manage their snoring by pushing the jaw forward, thus preventing the tongue from falling backward and obstructing the airway. As an example, the Office for Health Improvement and Disparities (OHID), a Department of Health and Social Care in the UK, stated in May 2024 that from 2022 to 2023, it was projected that 64.0% of adults aged 18 and above residing in England were either overweight or had obesity. During that same interval, it was estimated that 26.2% of adults had obesity, a figure almost in line with the previous annual statistic of 25.9%, from 2021 to 2022. Consequently, the rising prevalence of obesity is fuelling the expansion of the anti-snoring devices market.
The anti-snoring devices market covered in this report is segmented –
1) By Product Type: Mandibular Advancement Devices (MADS), Tongue Retaining Devices (TRD), Nasal Dilator, Chin Strap, Position Control, Pillow, Tongue Stabilizing Device (TSD), Expiratory Positive Airway Pressure (EPAP)
2) By Surgical Procedure: Uvulopalatopharyngoplasty (UP3), Laser-Assisted Uvula Palatoplasty (LAUP), Radiofrequency Ablation (RFA), Sclerotherapy, Pillar, Other Surgical Procedures
3) By Gender: Men, Women
4) By Age Group: Between 40 And 59 Years, 60 And Above Years, Below 40 Years
5) By End User: Hospitals, Community Healthcare, Sleep Clinics, Home Healthcare, Other End Users
Subsegments:
1) By Mandibular Advancement Devices (MADS): Adjustable MADS, Fixed MADS
2) By Tongue Retaining Devices (TRD): Soft TRD, Rigid TRD
3) By Nasal Dilator: External Nasal Dilators, Internal Nasal Dilators
4) By Chin Strap: Adjustable Chin Straps, Elastic Chin Straps
5) By Position Control: Positional Pillows, Sleep Positioners
6) By Pillow: Anti-Snoring Pillows, Contoured Pillows
Leading firms in the anti-snoring devices sector are focusing on the creation of sophisticated technologies, including unique wearable innovations, to boost comfort and efficiency. These cutting-edge wearable solutions encompass high-tech devices that are meant to be donned on the body, thereby observing, enhancing, or tracking diverse functions and activities. For instance, AppYea Inc., a technology firm based in Israel, unveiled the AppySleep device, a groundbreaking wearable solution, in September 2024. The AppySleep device is engineered to keep track of sleep patterns and identify snoring, thereby generating mild vibrations aimed at prompting users to switch positions and minimize snoring. The device's stylish, user-friendly design facilitates comfortable usage throughout the night and it integrates with a mobile application to provide individualized insights and recommendations for enhancing sleep quality.
Major companies operating in the anti-snoring devices market include:
• Sleeping Well LLC
• Apnea Sciences Corporation
• Somnomed Ltd.
• Airway Management Inc.
• Theravent Inc.
• Tomed Gmbh
• GSK plc
• MPowRx
• Innovative Health Care Pvt. Ltd.
• ResMed Inc.
• Fisher & Paykel Appliances Holdings Ltd.
• AccuMed Corp.
• MEDiTAS Ltd.
• Koninklijke Philips N.V.
• ImThera Medical Inc.
• Contour Products Inc.
• VVFLY Electronics Co. Ltd.
• ZQuiet
• The Pure Sleep Company
• Rhinomed Limited
• DentCare Dental Lab Pvt. Ltd.
• Signifier Medical Technologies LLC
• KARL STORZ SE & Co. KG
• Lumenis Be Ltd.
• Olympus Winter & IBE GMBH
• Urologix LLC
• Boston Scientific Corporation
• Teleflex Incorporated
• Richard Wolf GmbH
• biolitec AG
• Coloplast Corp.
• Nozovent
• Snoring Solutions Inc.
North America was the largest region in the anti-snoring devices market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global anti-snoring devices market report during the forecast period. The regions covered in the anti-snoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa